June 19th 2025
In this video interview, Michael Daines, MD, explains phase 3 data for Panzyga (Octapharma) for pediatric acute- onset neuropsychiatric syndrome (PANS).
Addressing Healthcare Inequities: Tailoring Cancer Screening Plans to Address Inequities in Care
View More
SimulatED™: Understanding the Role of Genetic Testing in Patient Selection for Anti-Amyloid Therapy
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
View More
Quantifying public-school students with disabilities experiencing homelessness
April 4th 2023Eric Rubenstein, PhD, assistant professor, Department of Epidemiology, Boston University School of Public Health, explains why continued data collection for public school students with disabilities that experience homelessness is crucial for better support and care in this population.